Press Resease

Hepatitis B Diagnostic Tests Market by Product Type (Point-of-care Testing Kits [Cassettes/Cards and Strips] and Enzyme Immunoassay Kits [Anti-hepatitis B core antibody test, Hepatitis B surface antigen test, Anti-hepatitis B surface antibody test]) and by End User (Hospitals, Diagnostic Centers, Clinics, and Home Care): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 23-Aug-2018 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-3291 Status : Published

Global Hepatitis B diagnostic tests market expected to generate revenue of around USD 1020 million by end of 2024, growing at a CAGR of around 6.5% between 2018 and 2024. Hepatitis B is a common and serious infectious disease of the liver, which is affecting millions of people in the entire world and the prevalence of the disease has been growing globally.

Description

The report covers forecast and analysis for the hepatitis B diagnostic tests market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the hepatitis B diagnostic tests market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hepatitis B diagnostic tests market on a global level.

In order to give the users of this report a comprehensive view of the hepatitis B diagnostic tests market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hepatitis B Diagnostic Tests Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the hepatitis B diagnostic tests market by segmenting the market based on product type, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the market is segmented as enzyme immunoassay kits and point-of-care testing kits. The enzyme immunoassay kits segment is further segmented as anti-hepatitis B core antibody test, hepatitis B surface antigen test, and anti-hepatitis B surface antibody test, and the point-of-care testing kits segment is sub-segmented as strips and cassettes/cards. On the basis of the end user, the hepatitis B diagnostic tests market is segmented as hospitals, diagnostic centers, clinics, and home care settings. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, the UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes demand for hepatitis B diagnostic tests market based on individual product type and end-user in all the regions and countries.

The report also includes detailed profiles of end players such as Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott Laboratories, Biogate Laboratories Ltd., DiaSorin S.p.A., Vista Diagnostics International, Meridian Bioscience, Inc., J.Mitra & Co. Ltd., General Biologicals Corporation, and Siemens Medical Solutions USA, Inc.

This report segments the global Hepatitis B Diagnostic Tests market as follows:

Global Hepatitis B Diagnostic Tests Market: Product Type Segment Analysis

  • Enzyme Immunoassay Kits 
    • Anti-hepatitis B core antibody test
    • Hepatitis B surface antigen test 
    • Anti-hepatitis B surface antibody test 
  • Point-of-care Testing Kits 
    • Strips 
    • Cassettes/Cards 

Global Hepatitis B Diagnostic Tests Market: End-User Segment Analysis

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Home Care

Global Hepatitis B Diagnostic Tests Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Hepatitis B Diagnostic Tests market, 2017 - 2024(USD Million)
    • 2.2. Global Hepatitis B Diagnostic Tests market: snapshot
  •  
  • Chapter 3. Hepatitis B Diagnostic Tests Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Hepatitis B Diagnostic Tests market drivers: impact analysis
      • 3.2.2. Increasing Prevalence of hepatitis B
      • 3.2.3. Growing demand for advanced diagnostics tools
      • 3.2.4. Rising initiatives by governments and industry players
    • 3.3. Market Restraints
      • 3.3.1. Global Hepatitis B Diagnostic Tests market restraints: impact analysis
      • 3.3.2. Lack of Standard Guidelines
    • 3.4. Opportunities
      • 3.4.1. Awareness about the need for early detection of hepatitis B infections
      • 3.4.2. Introduction of newer test kits
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by end user segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Hepatitis B Diagnostic Tests Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Hepatitis B Diagnostic Tests market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Hepatitis B Diagnostic Tests Market- Product Type Segment Analysis
    • 5.1. Global Hepatitis B Diagnostic Tests market: product overview
      • 5.1.1. Global Hepatitis B Diagnostic Tests market revenue share, by product type, 2017 and 2024
    • 5.2. Enzyme Immunoassay Kits
      • 5.2.1. Global Hepatitis B Diagnostic Tests market for Enzyme Immunoassay Kits, 2017 - 2024(USD Million)
      • 5.2.2. Anti-hepatitis B core antibody test, market for Enzyme Immunoassay Kits, 2017 - 2024(USD Million)
      • 5.2.3. Hepatitis B surface antigen test, market for Enzyme Immunoassay Kits, 2017 - 2024(USD Million)
      • 5.2.4. Anti-hepatitis B surface antibody test, market for Enzyme Immunoassay Kits, 2017 - 2024(USD Million)
    • 5.3. Point-of-care Testing Kits
      • 5.3.1. Global Hepatitis B Diagnostic Tests market for Point-of-care Testing Kits, 2017 - 2024 (USD Million)
      • 5.3.2. Strips Point-of-care Testing Kits Market, 2017 - 2024 (USD Million)
      • 5.3.3. Cassettes/Cards Point-of-care Testing Kits Market, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global Hepatitis B Diagnostic Tests Market- End-User Segment Analysis
    • 6.1. Global Hepatitis B Diagnostic Tests market: End User type overview
      • 6.1.1. Global Hepatitis B Diagnostic Tests market revenue share, by End User, 2017 and 2024
    • 6.2. Hospitals
      • 6.2.1. Global Hepatitis B Diagnostic Tests market for Hospitals, 2017 - 2024 (USD Million)
    • 6.3. Diagnostic Centers
      • 6.3.1. Global Hepatitis B Diagnostic Tests market for Diagnostic Centers, 2017 - 2024 (USD Million)
    • 6.4. Clinics
      • 6.4.1. Global Hepatitis B Diagnostic Tests market for Clinics,2017 - 2024(USD Million)
    • 6.5. Home Care
      • 6.5.1. Global Hepatitis B Diagnostic Tests market for Home Care,2017 - 2024(USD Million)
  •  
  • Chapter 7. Global Hepatitis B Diagnostic Tests Market- Regional Segment Analysis
    • 7.1. Global Hepatitis B Diagnostic Tests market: regional overview
      • 7.1.1. Global Hepatitis B Diagnostic Tests market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
      • 7.2.2. North America Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.2.3.2. U.S. Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.2.4.2. Rest of North America Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
      • 7.3.2. Europe Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024 (USD Million)
        • 7.3.3.2. U.K. Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.4.2. Germany Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.5.2. France Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.6. Italy
        • 7.3.6.1. Italy Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.6.2. Italy Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.7. Spain
        • 7.3.7.1. Spain Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.7.2. Spain Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.3.8. Rest of Europe
        • 7.3.8.1. Rest of Europe Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.8.2. Rest of Europe Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024 (USD Million)
      • 7.4.2. Asia Pacific Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.4.3. China
        • 7.4.3.1. China Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.3.2. China Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.4.2. Japan Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.4.5. India
        • 7.4.5.1. India Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.5.2. India Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.4.6. Southeast Asia
        • 7.4.6.1. Southeast Asia Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.6.2. Southeast Asia Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.7.2. Rest of Asia Pacific Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
      • 7.5.2. Latin America Hepatitis B Diagnostic Tests market revenue, by end user, 2017 - 2024(USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.5.3.2. Brazil Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.5.4.2. Rest of Latin America Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
      • 7.6.2. Middle East and Africa Hepatitis B Diagnostic Tests market revenue, by end user, 2017 - 2024(USD Million)
      • 7.6.3. GCC Countries
        • 7.6.3.1. GCC Countries Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.6.3.2. GCC Countries Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
      • 7.6.4. Rest of Middle East and Africa
        • 7.6.4.1. Rest of Middle East and Africa Hepatitis B Diagnostic Tests market revenue, by product type, 2017 - 2024(USD Million)
        • 7.6.4.2. Rest of Middle East and Africa Hepatitis B Diagnostic Tests market revenue, by End User, 2017 - 2024(USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Bio-Rad Laboratories, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. bioMérieux SA
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Abbott Laboratories
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Biogate Laboratories Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. DiaSorin S.p.A.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Vista Diagnostics International
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Meridian Bioscience, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. J.Mitra & Co. Ltd.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. General Biologicals Corporation
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Siemens Medical Solutions USA, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

Methodology

Free Analysis

The liver is an essential organ which filters blood, processes nutrients, and fights against infection. The inflammation of the liver is termed as Hepatitis. The inflammation of the liver affects its normal functionality. The infection is usually caused by a virus. Hepatitis B is a serious liver disease which is caused due to infection. Acute and chronic are two type of hepatitis B based on the severity of the disease. Acute Hepatitis B is a short-term infection which occurs within 6 months after somebody is tainted with the virus. Lifelong infection with the Hepatitis B virus is categorized under chronic hepatitis. Hepatitis B is a life-threatening infection and has become the main healthcare problem globally. The growing prevalence of the disease is developing an increased requirement for fast and early diagnosis; this is expected to propel the growth of hepatitis B diagnostic tests market over the forecast period. 

The global hepatitis B diagnostic tests market is segmented into product type, end user, and geography. Based on the product type the hepatitis B diagnostic tests market is segmented as a point of care testing kits and enzyme immunoassay kits. The point of care testing kits segment is sub-segmented into strips and cards/cassettes. By end user, the global hepatitis B diagnostic tests market is segmented into hospitals, diagnostic centers, clinics, and home care settings. The enzyme immunoassay kits segment is further segmented as anti-hepatitis B core antibody test, hepatitis B surface antigen test, and anti-hepatitis B surface antibody test.

Global Hepatitis B Diagnostic Tests Market
 
By geography, the global hepatitis B diagnostic tests market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific accounted for the highest share in the global hepatitis B diagnostic tests market in 2017 and is expected to remain dominant over the forecast period. The high prevalence of hepatitis B and the growing burden of disease in the region are key factors contributing towards the high share of hepatitis B diagnostic tests market in the region. North America is expected to grow at a significant rate in the global hepatitis B diagnostic tests market in the near future. The U.S. government is taking initiatives to diagnose the hepatitis B infection at early stages for treatment and to save the lives, which is expected to boost the growth of the market in the region. 

Some of the key players in the hepatitis B diagnostic tests market are Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott Laboratories, Biogate Laboratories Ltd., DiaSorin S.p.A., Vista Diagnostics International, Meridian Bioscience, Inc., J.Mitra & Co. Ltd., General Biologicals Corporation, and Siemens Medical Solutions USA, Inc.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social